Pumpkin Seeds: 11 Evidence-Based Health

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
751
Pumpkin Seeds: 11 Evidence-Based Health Benefits

http://www.greenmedinfo.com/blog/remarkable-h...mpkin-seed

Pumpkin seeds, like all edible seeds, pack an immense nutritional and medicinal punch. After all, they contain future worlds within their compact structure. As Emerson said, "the creation of a thousand forests is within one acorn."

In order to prepare their "babies" for survival outside the pumpkin, Nature equips these seeds with an extremely dense source of organically-bound nutrients, including exceptionally high levels of key, health-promoting minerals.

For example, a one cup serving (64 grams) of pumpkin seeds has 44% daily value (DV) of zinc, 22% of copper, 42% magnesium, 16% manganese, 17% potassium, and enough iron (17% DV) to improve iron-deficiency associated anemia. And remember, food-derived minerals are far more bioavailable and biocompatible than inorganic forms, as we recently discussed in the article: Is Your MultiVitamin Trying to Kill You?

But beyond the obvious nutritional virtues of the seed, recent scientific investigations have revealed that pumpkin seed meal, as well as its pressed oil, may have great therapeutic value in alleviating the following conditions:

Prostate Growth: pumpkin seed has been studied for its ability to inhibit testosterone-induced prostate growth, a common causative factor in benign prostatic hyperplasia. [ii] It was also proven safe and effective in a 2014 clinical trial comparing it to the drug Prozasin. More details here.
Postmenopausal Symptoms: Women supplemented with 2,000 mg of pumpkin seed oil over the course of 12 weeks were found to have reduced blood pressure, increased HDL cholesterol, as well as reduction in the severity of hormone insufficiency associated symptoms, e.g. hot flash, headaches and join pain.[iii] Additional experimental research indicates that adverse cardiovascular changes associated with estrogen deficiency, such as blood pressure and lipid abnormalities, can be mitigated with pumpkin seed oil. [iv]
Calcium-Oxalate Kidney Stones: According to a study performed in 1987 and published in the American Journal of Clinical Nutrition, children with calcium-oxalate crystals in their urine responded favorably to the supplementation of their diet with pumpkin seeds.[v]
Cardiovascular and Liver Disease: A mixture of flaxseed and pumpkin seed was found to have heart-protective and liver-protective properties in an animal study from 2008 published in the Journal of Food Chemistry & Toxicology.[vi]
Drug & Chemical Toxicity: The protein isolate of pumpkin seed has been shown to alleviate acetaminophen (Tylenol) toxicity on the liver,[vii] and as methotrexate-induced small intestine damage in an animal model.[viii] It has also been studied to protect against carbon tetrachloride-induced liver injury.[ix]
Arthritis: Pumpkin seed oil was found to compare favorably with the NSAID drug indomethacin in an experimental model of arthritis, but without causing liver damage, in a study published in 1995 in the journal of Pharmacological Research.[x]
Hypertension: Animals fed pumpkin seed oil were found to respond more favorably to conventional drug-treatment with Ace-inhibitors and Calcium Channel Blockers, likely because of its beneficial antioxidant properties.[xi]
Parasites: A preclinical canine study has shown that pumpkin seeds have significant activity against canine intestinal parasites.[xii]
Insomnia/Anxiety: Pumpkin seeds contain a high level of tryptophan (22mg/gram of pumpkin seed protein), the amino acid precursor to serotonin – which is itself converted to melatonin, the "sleep hormone," in the evening. Research published in 2007 in the Canadian Journal of Physiology and Pharmacology found that when de-oiled pumpkin seed was taken in combination with glucose, a clinical effect similar to that of pharmaceutical-grade tryptophan was achieved.[xiii] A 2005 study published in the journal Nutritional Neuroscience found that pumpkin seed sourced tryptophan in combination with carbohydrate was as effective as pharmaceutical tryptophan in reducing awake time during the night.
Androgenic Alopecia (i.e. male pattern baldness): A 2014 randomized, double-blind, placebo-controlled trial published in Evid Based Complement Alternat Med found that men receiving pumpkin seed oil saw 30-40% increased hair counts while the placebo group showed only 5-10% more hair count on average. Learn more in our report on the study here. Pumpkin Seed Oil Found to Help Reverse Balding.
Overactive Bladder/Urinary Disorders: A 2014 clinical trial found that pumpkin seed oil, at 10 grams a day for 12 weeks, was safe and effective in reducing Overactive Bladder Symptom Score (OABSS) in patients with Overactive Bladder. More details here.
These, of course, are only some of the experimentally confirmed beneficial properties of pumpkin seed. Like all foods, there are likely countless properties which within the right context, the right timing, and the right amount, fulfill Hippocrates' age-old and timelessly true proclamation that food can be our medicine. Stay abreast of new research on pumpkin seed oil and other pumpkin components on our database dedicated to the topic: Pumpkin Research.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Safety Tech in Fleets: Drivers Embrace Its Role

Updated Category News Views 4

Drivers Warming Up to Fleet Safety Tech Seems like most fleet drivers these days are eyeing safety tech through a fresher lens. Gone are the days when grumbling about privacy was the anthem of the disgruntled. The latest Linxup survey claims a whopping 77% of commercial fleet pros have hopped onto the safety train, happily trading privacy qualms for the perks of solid...

Continue Reading
S4 Capital's Monks: Leading in Global Digital Marketing

Updated Category News Views 3

Monks: Leading the Charge with AI So, here's the deal with S4 Capital's Monks being named a Leader in the 2026 Gartner Magic Quadrant for Global Digital Marketing Agencies. If you're tuning your ear to the modern marketing game, this move is huge. The global digital-first marketing juggernaut known as Monks is setting quite the bar. They're weaving AI into every stitch of...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 0

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading
Jeen's Real-Time AI Cost Management Unveiled

Updated Category News Views 2

Unmasking the Ghosts in AI Expenses Enterprises are thrashing around in the digital ocean of AI, yet many still can't see what's draining their coffers. It's not just the savant data scientists racking up the charges; it's every automated agent chipping away at resources—unnoticed until the bill finally lands. That's where Jeen is stepping in, flipping the script on...

Continue Reading
Hycroft Overhauls Board with Mining Heavyweights

Updated Category News Views 2

High-Caliber Recruits Steer Hycroft's Ambitious Path Hycroft Mining's move to bulk up its board ought to raise eyebrows across the mining landscape. By snagging some of the biggest names in the industry, they're not just shuffling the deck—they're bringing in a whole new game plan. If you're tracking NASDAQ:HYMC, this is news you don't brush off. The New Power Quartet...

Continue Reading
Ontario Airport Taps New Leadership Amid Growth Surge

Updated Category News Views 3

Fresh Faces at Ontario International’s Helm Ever find yourself wandering into the airport too early for a flight, soaking in its quiet buzz as planes rev up on the tarmac? Well, at Ontario International, there’s a new wrinkle in that familiar scene. Ontario International Airport Authority (OIAA) has shuffled its leadership deck, plucking Dr. Ronald O. Loveridge as the...

Continue Reading
Education's Future Explored at Reagan Institute Summit

Updated Category News Views 2

When Second Lady Usha Vance joins a summit, folks know it's a big deal. The Reagan Institute’s Education Summit is shaping up to be a showdown of ideas, tackling education’s role in a whirlwind of technological and political changes. This ain’t your average PTA meeting. We’re talking heavyweights like Utah Governor Spencer Cox and Colorado Governor Jared Polis...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 3

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
Claroty Earns Top Marks in OT Security Evaluation

Updated Category News Views 5

A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...

Continue Reading
Zepp Health's Q2 2026 Results: Growth Amid Struggles

Updated Category News Views 2

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Continue Reading

Top 5 Most Recently Viewed Articles

Allogene Therapeutics Enhances ALPHA3 Trial with New Regimen

Updated Category News Views 180

Allogene Therapeutics Advances ALPHA3 Trial with Standard Regimen Allogene Therapeutics, a pioneering biotechnology company in the world of allogeneic CAR T cell therapies, has recently made significant strides in its clinical research. The company has chosen to incorporate standard fludarabine and cyclophosphamide (FC) as the lymphodepletion regimen for its ALPHA3 trial....

Continue Reading
Best Egg Earns Distinguished Workplace Recognition for 2024

Updated Category News Views 58

Best Egg Celebrates Its Most Loved Workplace Achievement Best Egg, a prominent player in the fintech industry, proudly announces its recognition as one of America’s Top Most Loved Workplaces for 2024, marking a significant achievement as it ranks #57 on Newsweek's prestigious list for the second consecutive year. This accolade showcases the company’s commitment to...

Continue Reading
Heidrick & Struggles Announces Q4 and Full Year 2024 Financials

Updated Category News Views 161

Heidrick & Struggles Announces Upcoming Financial Results Heidrick & Struggles International, Inc. (NASDAQ: HSII) is gearing up to release its financial results for the fourth quarter and full year of 2024. The company, widely recognized for its exceptional leadership advisory services and on-demand talent solutions, is scheduled to host a conference call to share these...

Continue Reading
Glenn Fleischman Takes Charge as aytm's Chief Revenue Officer

Updated Category News Views 205

Glenn Fleischman Takes Charge as aytm's Chief Revenue Officer aytm, a premier agile consumer insights platform for notable brands and organizations, is excited to announce the appointment of Glenn Fleischman as their new Chief Revenue Officer (CRO). This strategic move aims to boost growth and reinforce the company's leading position in the realm of agile market research....

Continue Reading
Bureau Veritas Enhances Its Infrastructure Leadership in APAC

Updated Category News Views 43

Bureau Veritas Sets to Acquire The APP Group in an Expansion Move Bureau Veritas, a renowned global leader in testing, inspection, and certification services, has reached an agreement to acquire The APP Group, a significant player in the Assurance, Compliance, and Independent Verification services across the Asia-Pacific’s buildings and infrastructure sectors. This...

Continue Reading